Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024
With advancements in oncology practice, patients are living longer and returning for repeat courses of radiotherapy. Reirradiation (ReRT) is becoming a viable treatment option for patients. This single-institution, retrospective audit evaluates the number of patients with primary lung cancers who un...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Technical Innovations & Patient Support in Radiation Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405632425000381 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226958548762624 |
|---|---|
| author | Catherine Laferlita Yiota Nicolaou Katrina Woodford Nicholas Hardcastle Susan Harden Kenton Thompson |
| author_facet | Catherine Laferlita Yiota Nicolaou Katrina Woodford Nicholas Hardcastle Susan Harden Kenton Thompson |
| author_sort | Catherine Laferlita |
| collection | DOAJ |
| description | With advancements in oncology practice, patients are living longer and returning for repeat courses of radiotherapy. Reirradiation (ReRT) is becoming a viable treatment option for patients. This single-institution, retrospective audit evaluates the number of patients with primary lung cancers who underwent radical retreatment to the thorax in 2024 and categorises them according to the European Society for Radiotherapy and Oncology (ESTRO) and European Organisation for Research and Treatment of Cancer (EORTC) consensus definition. Of the 511 patients with primary lung cancer in our institution who returned for further radiotherapy in 2024, 42 received radical retreatment to the thorax. Inconsistencies were seen in documentation across patient information platforms in relation to cumulative dose assessment and minimal documentation of radiobiological considerations such as equivalent dose in 2 Gy fraction (EQD2) were discovered. As a result of this study, recommendations were made to improve current practice. |
| format | Article |
| id | doaj-art-bdc41c4eecaf4624a4cb8be98fbdbc77 |
| institution | Kabale University |
| issn | 2405-6324 |
| language | English |
| publishDate | 2025-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Technical Innovations & Patient Support in Radiation Oncology |
| spelling | doaj-art-bdc41c4eecaf4624a4cb8be98fbdbc772025-08-24T05:13:30ZengElsevierTechnical Innovations & Patient Support in Radiation Oncology2405-63242025-09-013510033710.1016/j.tipsro.2025.100337Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024Catherine Laferlita0Yiota Nicolaou1Katrina Woodford2Nicholas Hardcastle3Susan Harden4Kenton Thompson5Department of Radiation Therapy Services, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Corresponding author at: Department of Radiation Therapy Services, Peter MacCallum Cancer Centre, Melbourne, Australia.Department of Radiation Therapy Services, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, AustraliaDepartment of Radiation Therapy Services, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Department of Medical Imaging and Radiation Sciences, Monash University, AustraliaDepartment of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, AustraliaDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, AustraliaDepartment of Radiation Therapy Services, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, AustraliaWith advancements in oncology practice, patients are living longer and returning for repeat courses of radiotherapy. Reirradiation (ReRT) is becoming a viable treatment option for patients. This single-institution, retrospective audit evaluates the number of patients with primary lung cancers who underwent radical retreatment to the thorax in 2024 and categorises them according to the European Society for Radiotherapy and Oncology (ESTRO) and European Organisation for Research and Treatment of Cancer (EORTC) consensus definition. Of the 511 patients with primary lung cancer in our institution who returned for further radiotherapy in 2024, 42 received radical retreatment to the thorax. Inconsistencies were seen in documentation across patient information platforms in relation to cumulative dose assessment and minimal documentation of radiobiological considerations such as equivalent dose in 2 Gy fraction (EQD2) were discovered. As a result of this study, recommendations were made to improve current practice.http://www.sciencedirect.com/science/article/pii/S2405632425000381ReirradiationRadiotherapyLungCancerRadicalAudit |
| spellingShingle | Catherine Laferlita Yiota Nicolaou Katrina Woodford Nicholas Hardcastle Susan Harden Kenton Thompson Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024 Technical Innovations & Patient Support in Radiation Oncology Reirradiation Radiotherapy Lung Cancer Radical Audit |
| title | Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024 |
| title_full | Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024 |
| title_fullStr | Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024 |
| title_full_unstemmed | Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024 |
| title_short | Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024 |
| title_sort | reirradiation evaluation of the occurrence and type in cancer treatment for lung 2024 |
| topic | Reirradiation Radiotherapy Lung Cancer Radical Audit |
| url | http://www.sciencedirect.com/science/article/pii/S2405632425000381 |
| work_keys_str_mv | AT catherinelaferlita reirradiationevaluationoftheoccurrenceandtypeincancertreatmentforlung2024 AT yiotanicolaou reirradiationevaluationoftheoccurrenceandtypeincancertreatmentforlung2024 AT katrinawoodford reirradiationevaluationoftheoccurrenceandtypeincancertreatmentforlung2024 AT nicholashardcastle reirradiationevaluationoftheoccurrenceandtypeincancertreatmentforlung2024 AT susanharden reirradiationevaluationoftheoccurrenceandtypeincancertreatmentforlung2024 AT kentonthompson reirradiationevaluationoftheoccurrenceandtypeincancertreatmentforlung2024 |